Letter to the Editor

Øyvind Bakken Rognstad^{1

2

3}, Siri Kaldenbach^{4

5}, Tor A Strand^{6

7}

Affiliations

¹ Department of Medicine, Sykehuset Innlandet HF, Innlandet Hospital Trust, Anders Sandvigs gate 17, 2609 Lillehammer, Norway.
² Section for Colorectal Cancer Screening, Cancer Registry of Norway, Colorectal Screen Norway, Postbox 5313 Majorstuen, 0304 Oslo, Norway.
³ University of Oslo, Clinical Effectiveness Research Group, Institute of Health and Society, Postbox 1130 Blindern, 0318 Oslo, Norway.
⁴ University of Oslo, Institute of Clinical Medicine, Postbox 1171 Blinders, 0318 Oslo, Norway.
⁵ Department of Paediatric and Adolescent Medicine, Sykehuset Innlandet HF, Innlandet Hospital Trust, Anders Sandvigs gate 17, 2609 Lillehammer, Norway.
⁶ Research Department, Sykehuset Innlandet HF, Innlandet Hospital Trust, Anders Sandvigs gate 17, 2609 Lillehammer, Norway.
⁷ University of Bergen, Centre for International Health, Postbox 7804, 5020 Bergen, Norway.

Comment

Øyvind Bakken Rognstad et al. Eur J Prev Cardiol. 2022.

. 2022 Mar 30;29(4):e168-e169.

doi: 10.1093/eurjpc/zwab129.

Øyvind Bakken Rognstad^{1

2

3}, Siri Kaldenbach^{4

5}, Tor A Strand^{6

7}

¹ Department of Medicine, Sykehuset Innlandet HF, Innlandet Hospital Trust, Anders Sandvigs gate 17, 2609 Lillehammer, Norway.
² Section for Colorectal Cancer Screening, Cancer Registry of Norway, Colorectal Screen Norway, Postbox 5313 Majorstuen, 0304 Oslo, Norway.
³ University of Oslo, Clinical Effectiveness Research Group, Institute of Health and Society, Postbox 1130 Blindern, 0318 Oslo, Norway.
⁴ University of Oslo, Institute of Clinical Medicine, Postbox 1171 Blinders, 0318 Oslo, Norway.
⁵ Department of Paediatric and Adolescent Medicine, Sykehuset Innlandet HF, Innlandet Hospital Trust, Anders Sandvigs gate 17, 2609 Lillehammer, Norway.
⁶ Research Department, Sykehuset Innlandet HF, Innlandet Hospital Trust, Anders Sandvigs gate 17, 2609 Lillehammer, Norway.
⁷ University of Bergen, Centre for International Health, Postbox 7804, 5020 Bergen, Norway.

No abstract available

Comment on

Stage 1 hypertension, sex, and acute coronary syndromes during midlife: the Hordaland Health Study.
Kringeland E, Tell GS, Midtbø H, Igland J, Haugsgjerd TR, Gerdts E. Kringeland E, et al. Eur J Prev Cardiol. 2022 Feb 19;29(1):147-154. doi: 10.1093/eurjpc/zwab068. Eur J Prev Cardiol. 2022. PMID: 33993298
The need for better cardiac rehabilitation for women.
Khan HN, Asghar MA, Javaid MD. Khan HN, et al. Eur J Prev Cardiol. 2022 Mar 30;29(4):e167. doi: 10.1093/eurjpc/zwab114. Eur J Prev Cardiol. 2022. PMID: 34219167 No abstract available.